Quantcast

Latest FluMist Stories

2014-08-13 16:26:23

- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older - LYON, France, Aug. 13, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone(®) High-Dose (Influenza Vaccine)...

2014-07-30 12:30:26

LONDON, July 30, 2014 /PRNewswire/ -- Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and 2002 was 1.1; the mean Replikin Count increased twofold in 2010, threefold in 2012, and sixteen-fold in 2013, thus predicting the current outbreaks in humans. In the past, this technology has been shown to be able to predict...

2014-07-29 23:09:40

The National Foundation for Infectious Diseases (NFID) has been named a 2014 ASAE Power of A Silver Award winner for 'Keeping the Nation Flu-Focused,' a public awareness campaign to encourage everyone age six months and older to be vaccinated against influenza annually. Bethesda, Maryland (PRWEB) July 29, 2014 The National Foundation for Infectious Diseases (NFID) has been named a 2014 ASAE Power of A Silver Award winner for "Keeping the Nation Flu-Focused," a public...

2014-07-25 04:21:48

BEIJING, July 25, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2014, after market close on Thursday, August 14, 2014 EDT. The Company will host a conference call prior to the market opening on Friday, August 15, 2014, at 8:00 a.m. EDT (Friday, August 15, 2014 at 8:00 p.m. China Standard Time) to review the...

2014-07-23 08:30:15

BEIJING, July 23, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention ("Beijing CDC") to be a supplier of the seasonal influenza vaccine to the citizens of Beijing for 2014. The Beijing CDC plans to order a minimum of 1.2 million doses of the seasonal flu vaccine this year from four domestic vaccine manufacturers for its...

2014-07-22 08:32:20

- Largest U.S. influenza vaccine supplier, providing broad product portfolio, will distribute at least 65 million doses to help protect people across multiple age groups against the virus this season - SWIFTWATER, Pa., July 22, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone(®) (Influenza Vaccine) for the 2014-2015 influenza ("the flu") season have been released by the U.S. Food and Drug...

2014-07-17 12:29:49

MERIDEN, Conn., July 17, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that they have partnered with physicians from Velocity Urgent Care and launched a new initiative called Health-At-Work that offers on site influenza and other vaccinations to employers in Connecticut and surrounding regions. Unlike many vaccination providers, Health-At-Work offers the egg-free, highly pure Flublok influenza vaccine in the convenience of the employer's workplace. Employers can...

2014-07-14 08:25:49

BEIJING, July 14, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2014 Annual Meeting of Shareholders on Wednesday, August 27, 2014 at 9:00 a.m. Beijing Time. The meeting will be held at No. 39 Shangdi Xi Road, Haidian District, Beijing, PRC. All shareholders of record as of July 9, 2014 will be eligible to vote and are invited to attend. The primary agenda of the meeting is to...

2014-07-08 12:28:38

MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok. Every year influenza vaccine manufacturers must receive approval from the Agency for changes they make to the upcoming season's manufacturing process and product formulation, as the influenza vaccine is adapted annually. Early approval for Flublok will enable delivery on time to...

2014-07-02 16:24:52

-- The Novartis influenza vaccine portfolio in the US includes Flucelvax® and Fluvirin® CAMBRIDGE, Mass., July 2, 2014 /PRNewswire/ -- Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2014-2015 season. Novartis plans to ship a minimum of 30 million doses of vaccines (Flucelvax(®) [Influenza Virus Vaccine] and Fluvirin(® )[Influenza Virus Vaccine]) to the US market in advance of the peak of influenza season....


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'